...
首页> 外文期刊>RSC Advances >Novel indole based hybrid oxadiazole scaffolds with N-(substituted-phenyl)butanamides: synthesis, lineweaver–burk plot evaluation and binding analysis of potent urease inhibitors
【24h】

Novel indole based hybrid oxadiazole scaffolds with N-(substituted-phenyl)butanamides: synthesis, lineweaver–burk plot evaluation and binding analysis of potent urease inhibitors

机译:新型的基于吲哚的杂草二唑与N-(取代的苯基)丁酰胺的混合物:合成,lineweaver-burk图评估和有效的脲酶抑制剂的结合分析

获取原文

摘要

In the study presented herein, 4-(1 H -indol-3-yl)butanoic acid ( 1 ) was sequentially transformed in the first phase into ethyl 4-(1 H -indol-3-yl)butanoate ( 2 ), 4-(1 H -indol-3-yl)butanohydrazide ( 3 ) and 5-[3-(1 H -indol-3-yl)propyl]-1,3,4-oxadiazole-2-thiol ( 4 ) as a nucleophile. In the second phase, various electrophiles were synthesized by reacting substituted-anilines, 5a–j , with 4-chlorobutanoyl chloride ( 6 ) to afford 4-chloro- N -(substituted-phenyl)butanamides ( 7a–j ). In the final phase, nucleophilic substitution reaction of 4 was carried out with different electrophiles, 7a–j , to achieve novel indole based oxadiazole scaffolds with N -(substituted-phenyl)butamides ( 8a–j ). The structural confirmation of all the as-synthesized compounds was performed by spectral and elemental analysis. These molecules were screened for their in vitro inhibitory potential against urease enzyme and were found to be potent inhibitors. The results of enzyme inhibitory kinetics showed that compound 8c inhibited the enzyme competitively with a K _(i) value 0.003 μM. The results of the in silico study of these scaffolds were in full agreement with the experimental data and the ligands showed good binding energy values. The hemolytic study revealed their mild cytotoxicity towards cell membranes and hence, these molecules can be regarded as valuable therapeutic agents in drug designing programs.
机译:在本文提出的研究中,在第一相中将4-(1 H-吲哚-3-基)丁酸(1)依次转化为4-(1 H-吲哚-3-基)丁酸乙酯(2),4 -(1 H-吲哚-3-基)丁酰肼(3)和5- [3-(1 H-吲哚-3-基)丙基] -1,3,4-恶二唑-2-硫醇(4)亲核试剂。在第二阶段,通过使取代的苯胺5a–j与4-氯丁酰氯(6)反应,得到4-氯-N-(取代的苯基)丁酰胺(7a–j),合成了各种亲电试剂。在最后阶段,用不同的亲电试剂7a–j进行4的亲核取代反应,以得到带有N-(取代的苯基)丁酰胺(8a–j)的新型基于吲哚的恶二唑支架。通过光谱和元素分析对所有合成化合物进行结构确认。筛选了这些分子对尿素酶的体外抑制潜力,发现它们是有效的抑制剂。酶抑制动力学的结果表明,化合物8c以0.003μM的K_(i)值竞争性抑制酶。这些支架的计算机模拟研究的结果与实验数据完全一致,并且配体显示出良好的结合能值。溶血研究揭示了它们对细胞膜的轻度细胞毒性,因此,这些分子在药物设计程序中可以视为有价值的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号